
Overview
Wei Xue is a Pathologist and a General Surgeon practicing medicine in Staten Island, New York.
Dr. Xue is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Triple-Negative Breast Cancer, Lymphoid Hyperplasia, and Lymphofollicular Hyperplasia.
She is actively involved in clinical research, co-authoring 1 peer reviewed article.
Graduate Institution
Residency
Specialties
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
CUIMC/Presbyterian Hospital And Vanderbilt Clinic
Alejandro Gru, MD is the Leonard C. Harber Professor of Dermatology and Director of Dermatopathology at Columbia University Irving Medical Center. He is also the Director of the Dermatopathology Fellowship and holds a joint appointment with the Pathology & Cell Biology Department. Dr. Gru received his MD from the Universidad de Buenos Aires in Argentina. He completed his internship in Medicine and residency training in Anatomic Pathology, followed by fellowship training in Surgical Pathology, Hematopathology, and Dermatopathology at Washington University School of Medicine in St. Louis. He subsequently joined the faculty at Ohio State University as an Assistant Professor of Pathology and Dermatology prior to moving to the University of Virginia, where he was promoted to Associate Professor and then tenured Professor in the Department of Pathology. At the University of Virginia, he established the first cutaneous lymphoma multidisciplinary program and served as director of the Dermatopathology section and fellowship.Dr. Gru is the current President of the United States Cutaneous Lymphoma Consortium (USCLC) and has led the pathology initiatives of the international study in advanced stage cutaneous lymphomas (PROCLIPI), the USCLC lymphoma registry, and more recently the International T-cell Lymphoma Project (TCP 2.0). He is an associate editor for the Journal of Cutaneous Pathology and Seminars in Diagnostic Pathology. He serves on the editorial board of numerous academic journals, including the Journal of the American Academy of Dermatology, the American Journal of Surgical Pathology, Modern Pathology, and Histopathology, among others. Dr. Gru is highly rated in 32 conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Erythroderma, and Tissue Biopsy. Dr. Gru is board certified in Anatomic Pathology, Dermatopathology, and Hematopathology.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Ian Ganly is a General Surgeon practicing medicine in New York, New York. Dr. Ganly is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Tongue Cancer, Thyroidectomy, and Laryngectomy. Dr. Ganly is currently accepting new patients.
Rockefeller Outpatient Pavilion
William Jarnagin is a General Surgeon practicing medicine in New York, New York. Dr. Jarnagin is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Gallbladder Cancer, Hepatectomy, and Pancreatectomy. Dr. Jarnagin is currently accepting new patients.
Frequently Asked Questions about Dr. Wei Xue
Is Dr. Wei Xue a top-rated expert for Triple-Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Wei Xue is classified as an Advanced expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Wei Xue specialize in?
While Dr. Wei Xue is a Pathology, they have specific expertise in Triple-Negative Breast Cancer, Lymphoid Hyperplasia, and Lymphofollicular Hyperplasia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pathology.
Does Dr. Wei Xue participate in research or clinical trials?
Yes. Dr. Wei Xue has published 1 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Dr. Wei Xue's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Wei Xue accept my insurance?
Dr. Wei Xue accepts most major insurance plans, including Blue Cross Blue Shield and Humana. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Triple-Negative Breast Cancer
- Experienced
- Lymphofollicular HyperplasiaDr. Xue isExperienced. Learn about Lymphofollicular Hyperplasia.
- Lymphoid HyperplasiaDr. Xue isExperienced. Learn about Lymphoid Hyperplasia.

